Suppr超能文献

巨噬细胞半乳糖凝集素受体在介导血管性血友病因子清除中的新作用。

A novel role for the macrophage galactose-type lectin receptor in mediating von Willebrand factor clearance.

机构信息

Irish Centre for Vascular Biology, Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland.

Department of Basic Biomedical Sciences, University of North Dakota School of Medicine and Health Sciences, Grand Forks, ND.

出版信息

Blood. 2018 Feb 22;131(8):911-916. doi: 10.1182/blood-2017-06-787853. Epub 2017 Dec 27.

Abstract

Previous studies have shown that loss of terminal sialic acid causes enhanced von Willebrand factor (VWF) clearance through the Ashwell-Morrell receptor (AMR). In this study, we investigated (1) the specific importance of - vs -linked sialic acid in protecting against VWF clearance and (2) whether additional receptors contribute to the reduced half-life of hyposialylated VWF. α2-3-linked sialic acid accounts for <20% of total sialic acid and is predominantly expressed on VWF -glycans. Nevertheless, specific digestion with α2-3 neuraminidase (α2-3Neu-VWF) was sufficient to cause markedly enhanced VWF clearance. Interestingly, in vivo clearance experiments in dual mice demonstrated enhanced clearance of α2-3Neu-VWF even in the absence of the AMR. The macrophage galactose-type lectin (MGL) is a C-type lectin that binds to glycoproteins expressing terminal -acetylgalactosamine or galactose residues. Importantly, the markedly enhanced clearance of hyposialylated VWF in mice was significantly attenuated in the presence of an anti-MGL inhibitory antibody. Furthermore, dose-dependent binding of human VWF to purified recombinant human MGL was confirmed using surface plasmon resonance. Additionally, plasma VWF:Ag levels were significantly elevated in mice compared with controls. Collectively, these findings identify MGL as a novel macrophage receptor for VWF that significantly contributes to the clearance of both wild-type and hyposialylated VWF.

摘要

先前的研究表明,末端唾液酸的缺失会通过 Ashwell-Morrell 受体(AMR)导致 von Willebrand 因子(VWF)清除率增加。在本研究中,我们研究了(1)-连接和 -连接唾液酸在保护 VWF 免受清除方面的具体重要性,以及(2)是否有其他受体有助于降低低唾液酸化 VWF 的半衰期。α2-3 连接的唾液酸占总唾液酸的<20%,主要表达在 VWF 的聚糖上。尽管如此,用α2-3 神经氨酸酶(α2-3Neu-VWF)特异性消化足以引起 VWF 清除率的明显增加。有趣的是,在双 小鼠体内清除实验中,即使在没有 AMR 的情况下,α2-3Neu-VWF 的清除率也明显增加。巨噬细胞半乳糖型凝集素(MGL)是一种 C 型凝集素,它与表达末端 -乙酰半乳糖胺或半乳糖残基的糖蛋白结合。重要的是,在存在抗 MGL 抑制性抗体的情况下, 小鼠中低唾液酸化 VWF 的清除率明显降低。此外,使用表面等离子体共振证实了人 VWF 与纯化的重组人 MGL 之间的剂量依赖性结合。此外,与对照组相比, 小鼠的血浆 VWF:Ag 水平显著升高。总之,这些发现确定了 MGL 是 VWF 的一种新型巨噬细胞受体,它对野生型和低唾液酸化 VWF 的清除都有显著贡献。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验